search
Back to results

Study on the Effects of a Toothpaste in the Microbiome and Clinical Parameters in Patients With Oral Dysbiosis

Primary Purpose

Oral Dysbiosis

Status
Active
Phase
Phase 2
Locations
Spain
Study Type
Interventional
Intervention
Test
Placebo
Control
Sponsored by
Mucosa Innovations, S.L.
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional supportive care trial for Oral Dysbiosis focused on measuring Gum inflammation, Periodontal Dysbiosis, Oral Dysbiosis

Eligibility Criteria

18 Years - 70 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Clinical diagnose of gingivitis.
  • At least 20 teeth (3rd molars excluded).
  • Must Accept informed consent.

Exclusion Criteria:

  • Clinical diagnose of periodontitis.
  • With orthodontics.
  • With removable dentures.
  • With upper incisors restorated.
  • Tumours in soft or hard tissues of the mouth.
  • More than 5 caries lesions with immediate restorative need
  • Antibiotics intake less than one month ago.
  • Pregnant women.
  • Other clinic assay at the moment.
  • Dental prophylaxis less than 2 weeks before starting the study.

Sites / Locations

  • Departamento de Estomatología, Facultad de Odontología

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm Type

Experimental

Placebo Comparator

Active Comparator

Arm Label

Test product

Placebo product

Control product

Arm Description

Toothpaste including an olive product, betaine and xylitol.

Toothpaste with the same composition as the test product but without olive product, betaine and xylitol.

Toothpaste marketed for gingivitis with zinc mineral with antimicrobial activity.

Outcomes

Primary Outcome Measures

Change from Baseline Microbiota at 4 months
ADNr 16s genetic sequencing
Change from Baseline Salivary flow rate at 2 months and at 4 months
Unstimulated salivary flow rate recovery as per Navazesh
Change from Baseline Saliva pH at 2 months and at 4 months
pH meter
Change from Baseline Bleeding index at 2 months and at 4 months
Ainamo and Bay bleeding index indicating the percentage of bleeding from 0 (no bleeding) to 100 (maximum bleeding)
Change in Baseline Plaque index at 2 months and at 4 months
Tonetti plaque index
Change in Baseline Elastase at 2 months and at 4 months
ELISA

Secondary Outcome Measures

Change in Baseline nitrate and nitrite in saliva at 4 months
Ionic chromatography

Full Information

First Posted
July 7, 2022
Last Updated
May 24, 2023
Sponsor
Mucosa Innovations, S.L.
Collaborators
Universidad de Granada
search

1. Study Identification

Unique Protocol Identification Number
NCT05463484
Brief Title
Study on the Effects of a Toothpaste in the Microbiome and Clinical Parameters in Patients With Oral Dysbiosis
Official Title
Stop Oral Dysbiosis. Study on the Effects of a Toothpaste in the Inflammatory Profile, Microbiome and Other Oral Dysbiosis Parameters: A Controlled, Randomized, Double-blind Study. This Study is Part of the Stop Dysbiosis Project
Study Type
Interventional

2. Study Status

Record Verification Date
May 2023
Overall Recruitment Status
Active, not recruiting
Study Start Date
July 13, 2021 (Actual)
Primary Completion Date
February 28, 2023 (Actual)
Study Completion Date
July 15, 2023 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Mucosa Innovations, S.L.
Collaborators
Universidad de Granada

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
Dysbiosis is a situation in which the normal function of an ecological net is altered. In health there is a cross talk between the host and the microbiota in order to maintain and promote a state of eubiosis. In dysbiosis a state of inflammation, a loss of hydration, a change in pH, a loss of the barrier function are all allies of key pathogens that work against the host. Stop dysbiosis is a bigger multibranch project focussed on different aspects of clinical dysbiosis including this prospective interventional double blind randomised clinical trial. Stop dysbiosis comprises further clinical studies in several areas such as oral dysbiosis, skin dysbiosis, vaginal dysbiosis and cancer dysbiosis, between others. One of the most common dysbiosis of the mouth is periodontal and mucosa dysbiosis that courses with inflammation of the gingiva (gingivitis). This inflammation induces some enzymes that in a later stage destroy connective tissue. The current study beeing presented now is focussed to research the effect of a composition with Saliactive ® topically delivered to the oral cavity vehiculized in an everyday toothpaste (YOTUEL® microbiome toothpaste) in a group of patients with oral dysbiosis.
Detailed Description
Oral microbiota is formed by diverse bacteria, archea, protozoos, yeast and funghi. More than 700 species of bacteria have been identified in the mouth. These bacteria live in equilibria in conditions of health. When equilibria is lost, due to changes in microbiota or changes in the ecosystem, dysbiosis appears. Periodontal dysbiosis is the consequence of the accumulation of plaque and the increase of gram negative species capable of releasing virulence factors that maintain inflammation and bleeding that maintain the ecosystem in a disease promoting status. Oral hygiene is a daily personal protocol effective means of delivery different substances to the tissues of the oral cavity. Toothpaste, mouthrinse, topical gels, lozenges and sprays are the most common presentations used in the oral cavity. The standard of care in the oral compound is toothpaste used 2-3 times a day. The toothpaste that is going to be tested in the study does not contain any anymicrobial agent and includes an olive product, betaine and xylitol. Its efficacy will be tested measuring the inflammatory profile that includes plaque index and bleeding index, the microbiota population by genetic sequenciation of the ADNr 16s, the salivary flow, the colour ot teeth and the nitrates/nitrites ratio at baseline, after 2 months and 4 months using the product. Two controls will be also analysed to compare results, one with the same composition but without the 3 ingredients olive product, betaine and xylitol, and one product marketed as a toothpaste for gingivitis with an antibacterial ingredient. Assignation of the 100 subjects will be randomized and the products are blind for the subjects and the researcher.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Oral Dysbiosis
Keywords
Gum inflammation, Periodontal Dysbiosis, Oral Dysbiosis

7. Study Design

Primary Purpose
Supportive Care
Study Phase
Phase 2, Phase 3
Interventional Study Model
Parallel Assignment
Model Description
Three toothpastes will be included in the study; one with the composition including an olive product, betaine and xylitol, one with the same composition but without the olive product, betaine and xylitol, and one of a product marketed for gingivitis with and antimicrobial ingredient. Subjects are randomnly assigned and products will have a white label so that nor subject nor researcher will know the composition to be tested.
Masking
ParticipantCare ProviderInvestigatorOutcomes Assessor
Allocation
Randomized
Enrollment
100 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Test product
Arm Type
Experimental
Arm Description
Toothpaste including an olive product, betaine and xylitol.
Arm Title
Placebo product
Arm Type
Placebo Comparator
Arm Description
Toothpaste with the same composition as the test product but without olive product, betaine and xylitol.
Arm Title
Control product
Arm Type
Active Comparator
Arm Description
Toothpaste marketed for gingivitis with zinc mineral with antimicrobial activity.
Intervention Type
Combination Product
Intervention Name(s)
Test
Intervention Description
Toothpaste including a Saliactive® that is the combination of an olive product, betaine and xylitol.
Intervention Type
Combination Product
Intervention Name(s)
Placebo
Intervention Description
Toothpaste with the same composition as the test product but without Saliactive®.
Intervention Type
Combination Product
Intervention Name(s)
Control
Intervention Description
Toothpaste marketed for gingivitis with zinc citrate.
Primary Outcome Measure Information:
Title
Change from Baseline Microbiota at 4 months
Description
ADNr 16s genetic sequencing
Time Frame
4 months
Title
Change from Baseline Salivary flow rate at 2 months and at 4 months
Description
Unstimulated salivary flow rate recovery as per Navazesh
Time Frame
4 months
Title
Change from Baseline Saliva pH at 2 months and at 4 months
Description
pH meter
Time Frame
4 months
Title
Change from Baseline Bleeding index at 2 months and at 4 months
Description
Ainamo and Bay bleeding index indicating the percentage of bleeding from 0 (no bleeding) to 100 (maximum bleeding)
Time Frame
4 months
Title
Change in Baseline Plaque index at 2 months and at 4 months
Description
Tonetti plaque index
Time Frame
4 months
Title
Change in Baseline Elastase at 2 months and at 4 months
Description
ELISA
Time Frame
4 months
Secondary Outcome Measure Information:
Title
Change in Baseline nitrate and nitrite in saliva at 4 months
Description
Ionic chromatography
Time Frame
4 months
Other Pre-specified Outcome Measures:
Title
Change in Baseline Tooth colour at 2 months and at 4 months
Description
VITA Easyshade® V
Time Frame
4 months

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
70 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Clinical diagnose of gingivitis. At least 20 teeth (3rd molars excluded). Must Accept informed consent. Exclusion Criteria: Clinical diagnose of periodontitis. With orthodontics. With removable dentures. With upper incisors restorated. Tumours in soft or hard tissues of the mouth. More than 5 caries lesions with immediate restorative need Antibiotics intake less than one month ago. Pregnant women. Other clinic assay at the moment. Dental prophylaxis less than 2 weeks before starting the study.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Francisco Luis Mesa Aguado
Organizational Affiliation
Departamento de Estomatología, Facultad de Odontología
Official's Role
Principal Investigator
Facility Information:
Facility Name
Departamento de Estomatología, Facultad de Odontología
City
Granada
ZIP/Postal Code
18071
Country
Spain

12. IPD Sharing Statement

Plan to Share IPD
No
Citations:
PubMed Identifier
12670090
Citation
Tonetti MS. The future of periodontology: new treatments for a new era. J Int Acad Periodontol. 2002 Jul;4(3):110-4.
Results Reference
background
PubMed Identifier
1058834
Citation
Ainamo J, Bay I. Problems and proposals for recording gingivitis and plaque. Int Dent J. 1975 Dec;25(4):229-35.
Results Reference
background
PubMed Identifier
8215087
Citation
Navazesh M. Methods for collecting saliva. Ann N Y Acad Sci. 1993 Sep 20;694:72-7. doi: 10.1111/j.1749-6632.1993.tb18343.x. No abstract available.
Results Reference
background
PubMed Identifier
33186726
Citation
Barbadoro P, Ponzio E, Coccia E, Prospero E, Santarelli A, Rappelli GGL, D'Errico MM. Association between hypertension, oral microbiome and salivary nitric oxide: A case-control study. Nitric Oxide. 2021 Jan 1;106:66-71. doi: 10.1016/j.niox.2020.11.002. Epub 2020 Nov 10.
Results Reference
background
PubMed Identifier
32210245
Citation
Bescos R, Ashworth A, Cutler C, Brookes ZL, Belfield L, Rodiles A, Casas-Agustench P, Farnham G, Liddle L, Burleigh M, White D, Easton C, Hickson M. Effects of Chlorhexidine mouthwash on the oral microbiome. Sci Rep. 2020 Mar 24;10(1):5254. doi: 10.1038/s41598-020-61912-4.
Results Reference
background

Learn more about this trial

Study on the Effects of a Toothpaste in the Microbiome and Clinical Parameters in Patients With Oral Dysbiosis

We'll reach out to this number within 24 hrs